Guangming Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Guangming Yang has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
- Yang Pan
School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China
8 shared publications - Po Hu
School of Pharmacy, Nanjing University of Chinese Medicine, 138 Xianlin Avenue, Qixia District, Nanjing 210023, China
6 shared publications Binghui Yan
School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
2 shared publications- Xinzhu Wang
School of Pharmacy, Nanjing University of Chinese Medicine, 138 Xianlin Avenue, Qixia District, Nanjing 210023, China
2 shared publications Xuelin Ma
School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, 210023, Jiangsu, PR China
2 shared publicationsZhenhuan Wei
School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
2 shared publications
Latest Publications
- Open Access
- 8 December 2025
- Published by AccScience Publishing in Eurasian Journal of Medicine and Oncology
- p. 025380401
Unveiling the anti-pulmonary nodule effects of Puling Yin using network analysis and computational docking
Introduction: Pulmonary nodules, which are increasingly detected through computed tomography screening, currently lack optimal management options, particularly for small or benign lesions, for which surgical resection risks overtreatment and pharmacotherapy demonstrates limited efficacy. Objective: This study aims to validate Puling Yin (a 15:1 Taraxacum mongolicum/Ganoderma lucidum decoction) as a synergistic traditional Chinese medicine strategy for treating pulmonary nodules. Methods: The efficacy and safety of Puling Yin were evaluated using an in vivo pulmonary nodule model induced by Lewis. The synergy between T. mongolicum and G. lucidum was confirmed in vitro through CompuSyn analysis. Mechanistic insights were investigated using network pharmacology to identify overlapping targets. In addition, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis was employed to identify key signaling pathways, and molecular docking was used to assess the binding affinity of bioactive compounds to core targets. Results: Puling Yin significantly reduced Lewis-induced pulmonary nodules by 66% (52.50 ± 21.23 vs. 153.67 ± 40.62 nodules/lung in the control) without observable toxicity. CompuSyn analysis confirmed a synergistic interaction enabling lower effective doses of T. mongolicum and G. lucidum. Moreover, network pharmacology identified 701 overlapping targets, and KEGG enrichment analysis highlighted the phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT) signaling pathway as a central pathway. Molecular docking revealed high-affinity binding of key bioactives, such as indolelactic acid, to AKT serine/threonine kinase 1 (−9.8 kcal/mol), demonstrating simultaneous interference with inflammation, immune response, and proliferation pathways. Conclusion: Puling Yin effectively suppresses pulmonary nodules through synergistic multi-target actions that holistically modulate the nodule microenvironment, with its key bioactives contributing to therapeutic efficacy by targeting critical pathways, including the PI3K/AKT signaling pathway.
- 8 December 2025
- Published by AccScience Publishing in Eurasian Journal of Medicine and Oncology
- p. 025380401
Open AccessUnveiling the anti-pulmonary nodule effects of Puling Yin using network analysis and computational docking
Introduction: Pulmonary nodules, which are increasingly detected through computed tomography screening, currently lack optimal management options, particularly for small or benign lesions, for which surgical resection risks overtreatment and pharmacotherapy demonstrates limited efficacy. Objective: This study aims to validate Puling Yin (a 15:1 Taraxacum mongolicum/Ganoderma lucidum decoction) as a synergistic traditional Chinese medicine strategy for treating pulmonary nodules. Methods: The efficacy and safety of Puling Yin were evaluated using an in vivo pulmonary nodule model induced by Lewis. The synergy between T. mongolicum and G. lucidum was confirmed in vitro through CompuSyn analysis. Mechanistic insights were investigated using network pharmacology to identify overlapping targets. In addition, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis was employed to identify key signaling pathways, and molecular docking was used to assess the binding affinity of bioactive compounds to core targets. Results: Puling Yin significantly reduced Lewis-induced pulmonary nodules by 66% (52.50 ± 21.23 vs. 153.67 ± 40.62 nodules/lung in the control) without observable toxicity. CompuSyn analysis confirmed a synergistic interaction enabling lower effective doses of T. mongolicum and G. lucidum. Moreover, network pharmacology identified 701 overlapping targets, and KEGG enrichment analysis highlighted the phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT) signaling pathway as a central pathway. Molecular docking revealed high-affinity binding of key bioactives, such as indolelactic acid, to AKT serine/threonine kinase 1 (−9.8 kcal/mol), demonstrating simultaneous interference with inflammation, immune response, and proliferation pathways. Conclusion: Puling Yin effectively suppresses pulmonary nodules through synergistic multi-target actions that holistically modulate the nodule microenvironment, with its key bioactives contributing to therapeutic efficacy by targeting critical pathways, including the PI3K/AKT signaling pathway.
- Open Access
- 13 June 2025
- Published by MDPI AG in Pharmaceuticals
- Vol. 18 (6) , 884
The Efficacy of Combined Use of Huaier Granules in the Treatment of Primary Liver Cancer: An Updated Systematic Review and Meta-Analysis
Objective: Existing clinical data suggest that Huaier granules effectively improve the condition of PLC patients. However, their specific efficacy and safety in PLC patients remain unclear. This study aimed to investigate the effects of Huaier granules as an adjunctive therapy for PLC patients. Methods: This cohort study includes 4577 PLC patients, with data retrieved up to 2024. The patients were divided into the Huaier group (n = 2404) and a control group (n = 2173), and the treatment effects and safety between the two groups were compared. Review Manager 5.3 was used to analyze the clinical data. The fixed-effects and random-effects models were adopted. Stata 17.0 was used for sensitivity and bias analyses to evaluate publication bias. Results: Heterogeneity testing and analysis using a random-effects model showed that the combination of Huaier granules and conventional treatment significantly reduced the recurrence rate (OR = 0.65, 95% CI 0.50–0.85, p = 0.002) and improved the one-year survival rate (OR = 0.79, 95% CI 0.65–0.96, p = 0.02). Huaier granules also improved quality of life, reduced AFP levels (p < 0.00001), and significantly impacted immune function by altering the levels of the T lymphocyte subtypes CD3+, CD4+, CD8+ and the CD4+/CD8+ ratio. When Huaier granules were used in combination with other medications, no significant changes in side effects were observed. Conclusions: Huaier combination therapy shows good therapeutic efficacy and safety in PLC patients. However, this conclusion needs to be further validated through prospective clinical studies.
- 13 June 2025
- Published by MDPI AG in Pharmaceuticals
- Vol. 18 (6) , 884
Open AccessThe Efficacy of Combined Use of Huaier Granules in the Treatment of Primary Liver Cancer: An Updated Systematic Review and Meta-Analysis
Objective: Existing clinical data suggest that Huaier granules effectively improve the condition of PLC patients. However, their specific efficacy and safety in PLC patients remain unclear. This study aimed to investigate the effects of Huaier granules as an adjunctive therapy for PLC patients. Methods: This cohort study includes 4577 PLC patients, with data retrieved up to 2024. The patients were divided into the Huaier group (n = 2404) and a control group (n = 2173), and the treatment effects and safety between the two groups were compared. Review Manager 5.3 was used to analyze the clinical data. The fixed-effects and random-effects models were adopted. Stata 17.0 was used for sensitivity and bias analyses to evaluate publication bias. Results: Heterogeneity testing and analysis using a random-effects model showed that the combination of Huaier granules and conventional treatment significantly reduced the recurrence rate (OR = 0.65, 95% CI 0.50–0.85, p = 0.002) and improved the one-year survival rate (OR = 0.79, 95% CI 0.65–0.96, p = 0.02). Huaier granules also improved quality of life, reduced AFP levels (p < 0.00001), and significantly impacted immune function by altering the levels of the T lymphocyte subtypes CD3+, CD4+, CD8+ and the CD4+/CD8+ ratio. When Huaier granules were used in combination with other medications, no significant changes in side effects were observed. Conclusions: Huaier combination therapy shows good therapeutic efficacy and safety in PLC patients. However, this conclusion needs to be further validated through prospective clinical studies.
- Open Access
- 11 December 2024
- Published by Wiley in Aging Cell
- Vol. 24 (4) , e14445
Telomerase reverse transcriptase gene knock‐in unleashes enhanced longevity and accelerated damage repair in mice
While previous research has demonstrated the therapeutic efficacy of telomerase reverse transcriptase (TERT) overexpression using adeno‐associated virus and cytomegalovirus vectors to combat aging, the broader implications of TERT germline gene editing on the mammalian genome, proteomic composition, phenotypes, lifespan extension, and damage repair remain largely unexplored. In this study, we elucidate the functional properties of transgenic mice carrying the Tert transgene, guided by precise gene targeting into the Rosa26 locus via embryonic stem (ES) cells under the control of the elongation factor 1α (EF1α) promoter. The Tert knock‐in (TertKI) mice harboring the EF1α‐Tert gene displayed elevated telomerase activity, elongated telomeres, and extended lifespan, with no spontaneous genotoxicity or carcinogenicity. The TertKI mice showed also enhanced wound healing, characterized by significantly increased expression of Fgf7, Vegf, and collagen. Additionally, TertKI mice exhibited robust resistance to the progression of colitis induced by dextran sodium sulfate (DSS), accompanied by reduced expression of disease‐deteriorating genes. These findings foreshadow the potential of TertKI as an extraordinary rejuvenation force, promising not only longevity but also rejuvenation in skin and intestinal aging.
- 11 December 2024
- Published by Wiley in Aging Cell
- Vol. 24 (4) , e14445
Open AccessTelomerase reverse transcriptase gene knock‐in unleashes enhanced longevity and accelerated damage repair in mice
While previous research has demonstrated the therapeutic efficacy of telomerase reverse transcriptase (TERT) overexpression using adeno‐associated virus and cytomegalovirus vectors to combat aging, the broader implications of TERT germline gene editing on the mammalian genome, proteomic composition, phenotypes, lifespan extension, and damage repair remain largely unexplored. In this study, we elucidate the functional properties of transgenic mice carrying the Tert transgene, guided by precise gene targeting into the Rosa26 locus via embryonic stem (ES) cells under the control of the elongation factor 1α (EF1α) promoter. The Tert knock‐in (TertKI) mice harboring the EF1α‐Tert gene displayed elevated telomerase activity, elongated telomeres, and extended lifespan, with no spontaneous genotoxicity or carcinogenicity. The TertKI mice showed also enhanced wound healing, characterized by significantly increased expression of Fgf7, Vegf, and collagen. Additionally, TertKI mice exhibited robust resistance to the progression of colitis induced by dextran sodium sulfate (DSS), accompanied by reduced expression of disease‐deteriorating genes. These findings foreshadow the potential of TertKI as an extraordinary rejuvenation force, promising not only longevity but also rejuvenation in skin and intestinal aging.
- 5 September 2023
- Published by Taylor & Francis in Journal of Biomolecular Structure and Dynamics
- Vol. 42 (14) , 7467-7484
In silico screening-based discovery of benzamide derivatives as inhibitors of Rho-associated kinase-1 (ROCK1)
- 5 September 2023
- Published by Taylor & Francis in Journal of Biomolecular Structure and Dynamics
- Vol. 42 (14) , 7467-7484
In silico screening-based discovery of benzamide derivatives as inhibitors of Rho-associated kinase-1 (ROCK1)
- Open Access
Optimization of Neferine Purification Based on Response Surface Methodology and Its Anti-Metastasis Mechanism on HepG2 Cells
Liver cancer continues to be a focus of scientific research due to its low five-year survival rate. One of its main core issues is the high metastasis of cells, for which there is no effective treatment. Neferine was originally isolated from Plumula nelumbinis and demonstrated to have a good antitumor effect. In order to extract high-purity Neferine in a more efficient and environmentally friendly manner, response surface methodology (RSM) was used to optimize the isolation and purification procedures in this study. The extract conditions of a 7:3 ratio for the eluent of dichloromethane: methanol, 1:60 for the mass ratio of the extract amount: silica gel, and 3 mL/min of the elution flow rate were shown to be the optimal conditions. These conditions resulted in the highest yield of 6.13 mg per 66.60 mg of starting material, with productivity of 8.76% and purity of 87.04%. Compared with the previous methods, this method can prepare Neferine in large quantities more quickly. We subsequently evaluated the antitumor activity of the purified Neferine against HepG2 hepatic cancer cells. The purified Neferine was found to inhibit the proliferation of HepG2 cells through the CCK-8 assay, with an IC50 of 33.80 μM in 24 h, 29.47 μM in 48 h, 24.35 μM in 72 h and 2.78 μM in 96 h of treatment. Neferine at a concentration of 3 μM could significantly inhibit the migration and invasion abilities of the HepG2 cells in vitro. We also explored the mechanism of action of Neferine via Western blot. We showed that Neferine could reduce RhoA expression by effectively inhibiting the phosphorylation of MYPT1, thereby effectively exerting anti-metastasis activity against HepG2 cells. Thus, we have optimized the isolation procedures for highly pure Neferine by response surface methodology (RSM) in this study, and purified Neferine is shown to play an essential role in the anti-metastasis process of liver cancer cells. The Neferine purification procedure may make a wide contribution to the follow-up development of other anti-metastasis lead compounds.
Open AccessOptimization of Neferine Purification Based on Response Surface Methodology and Its Anti-Metastasis Mechanism on HepG2 Cells
Liver cancer continues to be a focus of scientific research due to its low five-year survival rate. One of its main core issues is the high metastasis of cells, for which there is no effective treatment. Neferine was originally isolated from Plumula nelumbinis and demonstrated to have a good antitumor effect. In order to extract high-purity Neferine in a more efficient and environmentally friendly manner, response surface methodology (RSM) was used to optimize the isolation and purification procedures in this study. The extract conditions of a 7:3 ratio for the eluent of dichloromethane: methanol, 1:60 for the mass ratio of the extract amount: silica gel, and 3 mL/min of the elution flow rate were shown to be the optimal conditions. These conditions resulted in the highest yield of 6.13 mg per 66.60 mg of starting material, with productivity of 8.76% and purity of 87.04%. Compared with the previous methods, this method can prepare Neferine in large quantities more quickly. We subsequently evaluated the antitumor activity of the purified Neferine against HepG2 hepatic cancer cells. The purified Neferine was found to inhibit the proliferation of HepG2 cells through the CCK-8 assay, with an IC50 of 33.80 μM in 24 h, 29.47 μM in 48 h, 24.35 μM in 72 h and 2.78 μM in 96 h of treatment. Neferine at a concentration of 3 μM could significantly inhibit the migration and invasion abilities of the HepG2 cells in vitro. We also explored the mechanism of action of Neferine via Western blot. We showed that Neferine could reduce RhoA expression by effectively inhibiting the phosphorylation of MYPT1, thereby effectively exerting anti-metastasis activity against HepG2 cells. Thus, we have optimized the isolation procedures for highly pure Neferine by response surface methodology (RSM) in this study, and purified Neferine is shown to play an essential role in the anti-metastasis process of liver cancer cells. The Neferine purification procedure may make a wide contribution to the follow-up development of other anti-metastasis lead compounds.
- 19 August 2022
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 149 (2) , 553-566
Neferine, a novel ROCK1-targeting inhibitor, blocks EMT process and induces apoptosis in non-small cell lung cancer
The compounds derived from Traditional Chinese Medicines have shown various pharmacological activities with unique advantages, especially in the aspect of antitumor. Neferine (Nef), a natural compound, extracted from green seed embryos of Lotus (Nelumbo nucifera Gaertn.) also exerts antitumor effects on cancers. In this study, the effects and mechanisms of Nef on epithelial-to-mesenchymal transition (EMT) process in non-small cell lung cancer (NSCLC) were evaluated. The results showed that Nef had the antitumor effects in vivo and in vitro. Nef significantly suppressed cell viability and induced apoptosis in NSCLC cells, with elevated reactive oxygen species and reduced BCL2/BAX ratio. Nef was also demonstrated to inhibit the invasion, metastasis and EMT process of NSCLC cells, and attenuate EMT-related changes of E-cadherin, N-cadherin and Vimentin at both transcriptional and translational levels. Moreover, we concluded that the inhibitory effects of Nef on EMT was achieved by targeting Rho-associated protein kinase 1, a protein mediating the process of EMT in various cancers. These results showed that Nef had a significant antitumor effect on NSCLC cells by inducing apoptosis and blocking EMT, providing the therapeutical prospect on NSCLC treatment.
- 19 August 2022
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 149 (2) , 553-566
Neferine, a novel ROCK1-targeting inhibitor, blocks EMT process and induces apoptosis in non-small cell lung cancer
The compounds derived from Traditional Chinese Medicines have shown various pharmacological activities with unique advantages, especially in the aspect of antitumor. Neferine (Nef), a natural compound, extracted from green seed embryos of Lotus (Nelumbo nucifera Gaertn.) also exerts antitumor effects on cancers. In this study, the effects and mechanisms of Nef on epithelial-to-mesenchymal transition (EMT) process in non-small cell lung cancer (NSCLC) were evaluated. The results showed that Nef had the antitumor effects in vivo and in vitro. Nef significantly suppressed cell viability and induced apoptosis in NSCLC cells, with elevated reactive oxygen species and reduced BCL2/BAX ratio. Nef was also demonstrated to inhibit the invasion, metastasis and EMT process of NSCLC cells, and attenuate EMT-related changes of E-cadherin, N-cadherin and Vimentin at both transcriptional and translational levels. Moreover, we concluded that the inhibitory effects of Nef on EMT was achieved by targeting Rho-associated protein kinase 1, a protein mediating the process of EMT in various cancers. These results showed that Nef had a significant antitumor effect on NSCLC cells by inducing apoptosis and blocking EMT, providing the therapeutical prospect on NSCLC treatment.
- Top Cited Papers
- 2 February 2022
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 290, 115066
Quercetin promotes cutaneous wound healing in mice through Wnt/β-catenin signaling pathway
- 2 February 2022
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 290, 115066
Top Cited PapersQuercetin promotes cutaneous wound healing in mice through Wnt/β-catenin signaling pathway